Elmar Kraus analyst DZ BANK

Currently out of the existing stock ratings of Elmar Kraus, 17 are a BUY (62.96%), 10 are a HOLD (37.04%).

Elmar Kraus

Work Performance Price Targets & Ratings Chart

Analyst Elmar Kraus, currently employed at DZ BANK, carries an average stock price target met ratio of 71.67% that have a potential upside of 16.74% achieved within 234 days. Previously, Elmar Kraus worked at STIFEL.

Elmar Kraus’s has documented 54 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ABBV, AbbVie at 04-Nov-2025.

Wall Street Analyst Elmar Kraus

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 1/21/2022. The price target of $291 was fulfilled within 75 days with a profit of $56.47 (24.08%) receiving and performance score of 3.21.

Average potential price target upside

BIIB Biogen LLY Eli Lilly and Company AZN AstraZeneca PLC ADR GILD Gilead Sciences AMGN Amgen ABBV AbbVie JNJ Johnson & Johnson MRK Merck mpany MDT Medtronic PLC SMMNY Siemens Healthineers AG ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$157

$-25.09 (-13.78%)

$118

26 days ago
(21-Nov-2025)

0/3 (0%)

$-18.3 (-10.44%)

Hold

$202

$19.91 (10.93%)

$287

1 months 11 days ago
(06-Nov-2025)

15/25 (60%)

$48.57 (31.66%)

215

Buy

$210

$27.91 (15.33%)

$213

1 months 16 days ago
(31-Oct-2025)

39/70 (55.71%)

$55.73 (36.12%)

121

Hold

$149

$-33.09 (-18.17%)

$152

2 months 7 days ago
(10-Oct-2025)

24/47 (51.06%)

$2.43 (1.66%)

266

Hold

2 months 23 days ago
(24-Sep-2025)

7/32 (21.88%)

$112.06 (70.95%)

255

Show more analysts

Please expand the browser size to see the chart

Which stock is Elmar Kraus is most bullish on?

Potential upside of $9.34 has been obtained for ABBV (ABBVIE)

What Year was the first public recommendation made by Elmar Kraus?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?